APA (7th ed.) Citation

HJ, v. d. H., SC, O., SAGM, C., AT, G., MB, O., IS, N., . . . T, M. (2020). Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies. HemaSphere, 5(1), e504. https://doi.org/10.1097/HS9.0000000000000504

Chicago Style (17th ed.) Citation

HJ, van der Horst, et al. "Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies." HemaSphere 5, no. 1 (2020): e504. https://doi.org/10.1097/HS9.0000000000000504.

MLA (9th ed.) Citation

HJ, van der Horst, et al. "Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies." HemaSphere, vol. 5, no. 1, 2020, p. e504, https://doi.org/10.1097/HS9.0000000000000504.